Home » FDA Plans Multi-Year Investigation Into Rare Side-Effect of Heparin
FDA Plans Multi-Year Investigation Into Rare Side-Effect of Heparin
The FDA has granted researchers millions of dollars to investigate a side effect of the blood thinner heparin, called thrombocytopenia, in which the blood loses platelets thanks to a release of abnormal blood clots.
Regulatory Focus
Regulatory Focus
Upcoming Events
-
07May
-
14May
-
30May